Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Women-Only Drug Treatment Services and Needs in Iran: The First Review of Current Literature Publisher Pubmed



Alammehrjerdi Z1 ; Daneshmand R2 ; Samiei M3 ; Samadi R4 ; Abdollahi M5 ; Dolan K1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Program of International Research and Training, National Drug and Alcohol Research Centre, Faculty of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
  2. 2. Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
  3. 3. Department of Psychiatry, School of Behavior Sciences, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
  4. 4. Psychiatry and Behavioral Sciences Research Center, Department of Psychiatry, Mashhad University of Medical Sciences, Mashhad, Iran
  5. 5. Department of Toxicology and Pharmacology, Faculty of Pharmacy, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: DARU# Journal of Pharmaceutical Sciences Published:2016


Abstract

Background: Iran (Persia) has a women-only drug treatment system. However, literature is not documented. The current study aimed to review the development of women-only drug treatment and harm reduction services (WODTHRS) and the factors associated with treatment entry and outcomes in Iran. The review was based on a comprehensive search for all literature focusing on WODTHRS in Iran. Methods: Data were collected by conducting systematic searching of scientific English and Persian databases and grey literature. This was done in line with Cochrane Guideline for conducting systematic reviews. Overall, 19,929 studies were found. But, only 19 original studies were included after excluding non-relevant studies. Results: The review findings indicate how WODTHRS have been developed in the past 15 years. The review findings underscore the roles of numerous factors in treatment entry such as the side effects of illicit drug use. In addition, cognitive-behavioral interventions, methadone treatment and some factors outside drug treatment such as family support increase positive treatment outcomes among women. In contrast, financial problems as well as other factors such as insufficient medical, psychiatric and social work services hamper treatment entry and positive treatment outcomes. Conclusions: The review results highlight that eliminating barriers to treatment entry and positive treatment outcomes should be addressed. Conducting randomized controlled trials is needed to evaluate the effectiveness of WODTHRS. This issue should address the factors influencing service utilization to incorporate the best practice for women. The evaluation of the long-term efficacy of WODTHRS is a critical research gap which should be addressed in future studies. © 2016 Alam-mehrjerdi et al.
Related Docs
View other Related Docs
1. Drug Use Treatment and Harm Reduction Programs in Iran: A Unique Model of Health in the Most Populated Persian Gulf Country, Asian Journal of Psychiatry (2015)
2. Epidemiology of Hiv in Iran, Current HIV Research (2020)
3. Methamphetamine Use and Treatment in Iran: A Systematic Review From the Most Populated Persian Gulf Country, Asian Journal of Psychiatry (2015)
4. Hiv Prevalence Among People Who Inject Drugs (Pwid) and Related Factors in Iran: A Systematic Review, Meta-Analysis and Trend Analysis, Addiction (2020)
5. Oral Health Determinants Among Female Addicts in Iran, Contemporary Clinical Dentistry (2015)
6. Awareness and Attitude Towards Opioid and Stimulant Use and Lifetime Prevalence of the Drugs: A Study in 5 Large Cities of Iran, International Journal of Health Policy and Management (2019)
7. Hiv in Iran: Onset, Responses, and Future Directions, AIDS (2021)
8. The Persian Methamphetamine Use in Methadone Treatment in Iran: Implication for Prevention and Treatment in an Upper-Middle Income Country, DARU# Journal of Pharmaceutical Sciences (2015)
Experts (# of related papers)
View all Related Experts
Afarin Rahimi-Movaghar (6)
Mohammad Effatpanah (5)
Other Related Docs
9. An Intervention to Improve Hcv Testing, Linkage to Care, and Treatment Among People Who Use Drugs in Tehran, Iran: The Enhance Study, International Journal of Drug Policy (2019)
10. Predictors of Time to Relapse in Amphetamine-Type Substance Users in the Matrix Treatment Program in Iran: A Cox Proportional Hazard Model Application, BMC Psychiatry (2016)
11. Prevalence of Injecting Drug Use and Hiv, Hepatitis B, and Hepatitis C in People Who Inject Drugs in the Eastern Mediterranean Region: A Systematic Review and Meta-Analysis, The Lancet Global Health (2023)
12. Crystal Methamphetamine Use and Its Correlates in Women Engaged in Sex Work in a Developing Country Setting, Drug and Alcohol Dependence (2018)
13. Motivational Interviewing Can Facilitate Entry to Matrix Treatment for Methamphetamine Dependence, Iranian Journal of Psychiatry and Behavioral Sciences (2018)
14. The Correlation Between Strength and Range of Motion of the Neck Muscles and Opium Smoking in Iran, Frontiers in Psychiatry (2023)
15. Methamphetamine Use Among Patients Undergoing Methadone Maintenance Treatment in Iran; a Threat for Harm Reduction and Treatment Strategies: A Qualitative Study, International Journal of High Risk Behaviors and Addiction (2016)
16. Concordance Assessment Between Self-Reports of Substance Use and Urinalysis: A Population-Based Study in Mashhad, Iran, Journal of Ethnicity in Substance Abuse (2020)
17. Methamphetamine Dependence Among Iranian Female Methadone Patients: A Cross-Sectional Survey of Three Cities of Iran, Iranian Journal of Psychiatry and Behavioral Sciences (2018)
18. Transition to Injecting Drug Use in Iran: A Systematic Review of Qualitative and Quantitative Evidence, International Journal of Drug Policy (2015)
19. Research Paper: Amphetamine Type Stimulants Use in the Adult Population of Tehran: Implications for Long Term Rehabilitation, Iranian Rehabilitation Journal (2017)
20. Low Hiv Testing Rate and Its Correlates Among Men Who Inject Drugs in Iran, International Journal of Drug Policy (2016)
21. Methamphetamine Dependence and Technology-Based Interventions in Iran, Iranian Journal of Psychiatry and Behavioral Sciences (2018)
22. Matrix Model for Methamphetamine Dependence Among Iranian Female Methadone Patients: The First Report From the Most Populated Persian Gulf Country, Iranian Rehabilitation Journal (2017)
23. Challenges and Successes of Harm Reduction Services in Drop-In Centers: Perspectives of Service Providers, International Journal of High Risk Behaviors and Addiction (2017)
24. Demographic and Mental History-Related Data Predicted Occurrence of Psychosis in Metamphetamine Users, Psychiatry Research (2016)
25. High-Risk Behaviors Among Regular and Casual Female Sexworkers in Iran: A Report Fromwestern Asia, Iranian Journal of Psychiatry and Behavioral Sciences (2018)
26. Estimation of Hiv Incidence and Its Trend in Three Key Populations in Iran, PLoS ONE (2018)
27. Relationship Between Hardiness and Addiction Potential in Medical Students, Iranian Journal of Psychiatry and Behavioral Sciences (2016)
28. Comparison of Continuous Performance Test Results of Former Morphine and Methamphetamine Users During the Early Abstinence Phase, Iranian Journal of Psychiatry and Behavioral Sciences (2018)
29. Declining Trends in Hiv and Other Sexually Transmitted Infections Among Female Sex Workers in Iran Could Be Attributable to Reduced Drug Injection: A Cross-Sectional Study, Sexually Transmitted Infections (2020)
30. The Evolution of Addiction Treatment and Harm Reduction Programs in Iran: A Chaotic Response or a Synergistic Diversity?, Addiction (2020)